BAM Logo

ROS1 Translocation for non-small cell lung carcinoma (NSCLC)

EPTIS factsheet 780655 | Last revision 2020-10-29 | URL: https://www.eptis.bam.de/pts780655 https://www.eptis.bam.de/pts780655

PT provider
Based in Australia
Language(s) English
Remarks Please note that the ROS1 program you must select which of the 3 tested properties you would like to receive.
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Unstained formalin fixed paraffin sections comprising of composite tissue block to be stained/processed/interpreted for ROS1 ROS1 - FISH -
ROS1 - Molecular -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (1 case per survey/1 survey)
Year of first operation
Contact details of the PT provider
Provider Contact person
Suite 201/8 Herbert Street
St Leonards, 2065

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Mr Rhys Judd
Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5